Screener
Design Therapeutics, Inc. DSGN Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Design Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026.
- Filed
- Apr 28, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-187063
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total current assets | 227,049 | 223,784 |
| Property and equipment, net | 824 | 981 |
| Right-of-use asset | 2,569 | 1,438 |
| Total assets | $230,442 | $226,203 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $2,276 | $2,312 |
| Accrued expenses and other current liabilities (including related party amounts of $890 as of December 31, 2025) | 7,914 | 10,743 |
Item 1. Financial Statements.
FAQ
- What is Design Therapeutics, Inc.'s total assets?
- Design Therapeutics, Inc. (DSGN) reported total assets of $230.44M in Q1 2026.
- How has Design Therapeutics, Inc.'s total assets changed year-over-year?
- Design Therapeutics, Inc.'s total assets decreased by 3.0% year-over-year, from $237.48M to $230.44M.
- What is the long-term trend for Design Therapeutics, Inc.'s total assets?
- Over 5 years (2020 to 2025), Design Therapeutics, Inc.'s total assets has grown at a 44.0% compound annual growth rate (CAGR), from $36.52M to $226.2M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Design Therapeutics, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude